Cadre Holdings Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Cadre Holdings Inc 's ROA in the second quarter of 2026?
Cadre Holdings inc achieved a return on average assets (ROA) of 4.3 % in its second quarter of 2026, which is below Cadre Holdings Inc 's average return on assets, which stands at 5.06%.

ROA fell compared to the first quarter of 2026, despite the net income growth of 477.57% from the first quarter of 2026.

However, within the Healthcare sector 167 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 1227 to 1264.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	15.85 %	34.5 %	18.55 %	28.42 %	33.96 %
Y / Y Net Income Change	-6.58 %	-78.64 %	-9.58 %	199.34 %	-2.83 %
Net Income (TTM) in million	36	37	44	45	38
Return On Assets (TTM)	4.3 %	4.56 %	5.87 %	6.29 %	5.62 %
CDRE's Total Ranking	# 1264	# 1227	# 986	# 1080	# 1025
Total Assets (TTM) in million	917	880	770	790	792
Seq. Total Assets Change	4.27 %	14.25 %	-2.51 %	-0.24 %	21.05 %
Seq. Net Income Change	477.57 %	-83.18 %	7.29 %	-10.4 %	32.04 %

CDRE's 5 Years Annual ROA >> Back to CDRE Management Effectiveness >> Compare CDRE ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 46
Sector	# 168
Overall	# 1300

Return On Assets Statistics
High	Average	Low
9.42 %	5.06 %	-2.56 %
(Dec 31 2023)		(Jun 30 2022)

Financial Statements
Cadre Holdings Inc 's Assets	$ 917 million	CDRE's Balance sheet
Cadre Holdings Inc 's Income	$ 11 million	Quarterly CDRE's Income Statement
CDRE's Income by Division		See CDRE's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	18.55 %	51.18 %	10 %	27.76 %	-
Total Assets in million	770	650	430	391	306
Y / Y Net Income Change	22.16 %	-6.49 %	563.93 %	-54.03 %	-
Net Income in million	44	36	39	6	13
Annual Return On Assets	5.73 %	5.56 %	8.99 %	1.49 %	4.14 %

CDRE's 5 Years Annual ROA >> Back to CDRE Management Effectiveness >> Compare CDRE ROA to its Competitors

Comment on CDRE's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 5.73 % compared to prior year, due to annual net income growth of 22.16 % to $44.14 million, while value of Cadre Holdings Inc 's overall assets grew just by 18.55 % to $770.03 million, compared to $770.03 a year before.

More Return On Assets Ratios
CDRE's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CDRE's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CDRE's Competitors
Subscribers only: Roa for Cadre Holdings Inc 's Suppliers
Subscribers only: Return On Assets for CDRE's Customers

You may also want to know
CDRE's Roi	CDRE's Inventory Turnover Ratio	CDRE's Growth Rates	CDRE's Dividend Comparisons
	CDRE's Profitability Ratios	CDRE's Asset Turnover Ratio	CDRE's Dividend Growth
CDRE's Roe	CDRE's Valuation Ratios	CDRE's Financial Strength Ratios	CDRE's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Ligand Pharmaceuticals Incorporated	11.68 %
Theravance Biopharma inc	11.68 %
Carlisle Companies Incorporated	11.62 %
Encompass Health Corporation	11.60 %
Protagonist Therapeutics inc	11.02 %
Agilent Technologies inc	10.97 %
Prestige Consumer Healthcare Inc	10.90 %
Lemaitre Vascular Inc	10.90 %
Ufp Technologies Inc	10.85 %
Progyny Inc	10.66 %
Regeneron Pharmaceuticals Inc	10.60 %
Johnson and Johnson	10.60 %
Tenet Healthcare Corp	10.49 %
Bristol myers Squibb Company	10.27 %
Solventum Corporation	10.13 %
Globus Medical Inc	10.04 %
Universal Health Services Inc	9.92 %
Entrada Therapeutics Inc	9.51 %
Amgen Inc	9.48 %
National Healthcare Corp	9.28 %
Tactile Systems Technology Inc	9.17 %
Bioventus Inc	9.08 %
Infusystem Holdings Inc	8.63 %
Penumbra Inc	8.63 %
Utah Medical Products Inc	8.50 %
Boston Scientific Corporation	8.34 %
3m Company	8.27 %
Jazz Pharmaceuticals Plc	8.19 %
Pediatrix Medical Group Inc	8.09 %
Veracyte Inc	8.04 %

Date modified: 2026-09-11T10:05:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.